期刊
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
卷 48, 期 7, 页码 2245-2258出版社
SPRINGER
DOI: 10.1007/s00259-020-05099-w
关键词
PET; Tau; Aβ Alzheimer’ s disease; MCI; Dementia
资金
- Vrije Universiteit Amsterdam
- Swedish Research Council
- Knut and Alice Wallenberg foundation
- Marianne and Marcus Wallenberg foundation
- Strategic Research Area MultiPark (Multidisciplinary Research in Parkinson's disease) at Lund University
- Swedish Alzheimer Foundation
- Swedish Brain Foundation
- Medical Faculty at Lund University
- Region Skane
- Parkinson foundation of Sweden
- Parkinson Research Foundation
- Skane University Hospital Foundation
- Swedish federal government under the ALF agreement
- Alzheimer's Society Junior Fellowship [ASJF-17-011, P30AG062422, P01-AG019724, R01AG038791, R01-NS050915, K99 AG065501, R01 AG045611]
- Alzheimer's Association [AACSF-19-617663]
- Rainwater Charitable Foundation (GDR)
- GE Healthcare
- Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
- DOD ADNI (Department of Defense) [W81XWH-12-2-0012]
- National Institute on Aging
- National Institute of Biomedical Imaging and Bioengineering
- Alzheimer's Drug Discovery Foundation
- Araclon Biotech
- Biogen
- Bristol-Myers Squibb Company
- CereSpir, Inc.
- Cogstate
- Elan Pharmaceuticals, Inc.
- Eli Lilly and Company
- EuroImmun
- F. Hoffmann-La Roche Ltd.
- Canadian Institutes of Health Research
- Fonds de Recherche du Quebec - Sante (FRQ-S)
- Pfizer Canada
- J. L. Levesque Foundation
- Lemaire Foundation
- Douglas Hospital Research Centre and Foundation
- Government of Canada
- Canada Fund for Innovation
- Alzheimer's Association Grant
- Alzheimer Society of Canada
- Canada Institutes of Health Research [PJT162091, PJT-148963]
- Bundy Academy
- AbbVie
- Alzheimer's Association
- BioClinica, Inc.
- Eisai Inc.
- McGill University
The study revealed that age, MMSE score, and AD-signature cortical thickness were strongly associated with tau PET positivity in Alzheimer's disease and mild cognitive impairment patients with Aβ positivity, while the presence of Aβ was the strongest predictor of a positive tau PET scan in non-AD neurodegenerative disorder patients and cognitively unimpaired individuals.
Purpose A substantial proportion of amyloid-beta (A beta)+ patients with clinically diagnosed Alzheimer's disease (AD) dementia and mild cognitive impairment (MCI) are tau PET-negative, while some clinically diagnosed non-AD neurodegenerative disorder (non-AD) patients or cognitively unimpaired (CU) subjects are tau PET-positive. We investigated which demographic, clinical, genetic, and imaging variables contributed to tau PET status. Methods We included 2338 participants (430 A beta+ AD dementia, 381 A beta+ MCI, 370 non-AD, and 1157 CU) who underwent [F-18]flortaucipir (n = 1944) or [F-18]RO948 (n = 719) PET. Tau PET positivity was determined in the entorhinal cortex, temporal meta-ROI, and Braak V-VI regions using previously established cutoffs. We performed bivariate binary logistic regression models with tau PET status (positive/negative) as dependent variable and age, sex, APOE epsilon 4, A beta status (only in CU and non-AD analyses), MMSE, global white matter hyperintensities (WMH), and AD-signature cortical thickness as predictors. Additionally, we performed multivariable binary logistic regression models to account for all other predictors in the same model. Results Tau PET positivity in the temporal meta-ROI was 88.6% for AD dementia, 46.5% for MCI, 9.5% for non-AD, and 6.1% for CU. Among A beta+ participants with AD dementia and MCI, lower age, MMSE score, and AD-signature cortical thickness showed the strongest associations with tau PET positivity. In non-AD and CU participants, presence of A beta was the strongest predictor of a positive tau PET scan. Conclusion We identified several demographic, clinical, and neurobiological factors that are important to explain the variance in tau PET retention observed across the AD pathological continuum, non-AD neurodegenerative disorders, and cognitively unimpaired persons.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据